Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 22, 2011

The Majority of Surveyed U.S. Neurologists Selected Tysabri as the Most Effective Therapy for the Treatment of Relapsing-Remitting Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
The Majority of Surveyed U.S. Neurologists Selected Tysabri as the Most Effective Therapy for the Treatment of Relapsing-Remitting Multiple Sclerosis,…
MS Research Study and Reports

April 22, 2011

UCSF Study Revisits First Clinical Trial to Treat Multiple Sclerosis Decades Later

  • MS Research Study and Reports
    /
April 21, 2011 Tracking down nearly all 372 multiple sclerosis patients involved in a pivotal clinical trial of a drug…
MS Research Study and Reports

April 22, 2011

Pediatric MS: Partnering with Your Child’s School

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
  • National MS Society Related
    /
The National MS Society and MS Learn Online present… New Feature Presentation: Pediatric MS: Partnering with Your Child’s School  A video webcast that explores……
Additional MS resource sites

April 21, 2011

Pharmaceutical- Patient Resources for financial assistance and education

  • Additional MS resource sites
    /
If you need assistance with paying for your MS medication, have you tried contacting the patient assistance program for the…
Additional MS resource sites

April 21, 2011

Acorda Therapeutics announces US patent for multiple sclerosis drug “Ampyra”

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
With no competition, shall there be higher prices? April 21, 2011 (Source: Datamonitor) Acorda Therapeutics, Inc., a biotechnology company, has announced…
Alternative therapies and devices for Multiple Sclerosis (MS)

April 21, 2011

Biogen surges on data for MS oral drug candidate

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
On Thursday April 21, 2011, 12:49 pm EDT NEW YORK (AP) — Shares of Biogen Idec Inc. rocketed to an…
MS Drug Therapies

April 19, 2011

European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVONEX® PEN™ for patients with relapsing multiple sclerosis (MS)

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
News Medical Biogen Idec announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has…
MS Drug Therapies

April 19, 2011

Duke Researcher Receives $44,000 Grant for Multiple Sclerosis Research

  • MS Research Study and Reports
    /
 Duke Researcher Receives $44,000 Grant for Multiple Sclerosis Research Bryan Cullen, PhD, to study Metagenomic Characterization of Viral  Infection in Multiple Sclerosis Raleigh, N.C.…
MS Research Study and Reports

April 19, 2011

Multiple sclerosis tied to low sun, mono virus

  • MS Research Study and Reports
    /
  • Vitamins and Supplements
    /
April 19, 2011 –  The odds of developing multiple sclerosis may be higher in people who’ve had infectious mononucleosis and…
MS Research Study and Reports

April 18, 2011

Scripps closer to knocking-out, multiple sclerosis

  • MS Research Study and Reports
    /
By JEFF OSTROWSKI Palm Beach Post Staff Writer JUPITER — Researchers at Scripps Florida say they’ve found a way to stop multiple…
MS Research Study and Reports

Categories

Latest Blog Posts